Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NanoCarrier Co. Ltd.

www.nanocarrier.co.jp

Latest From NanoCarrier Co. Ltd.

Whiz Looks To Axcelead To Help Build Lagging Japan Venture Ecosystem

Japan was never known for its healthcare-focused venture capital funds, but Whiz Partners, Inc. is looking to fill what it sees as a void, helped by some heavy corporate hitters, and a major new collaboration with Takeda's spun out preclinical development operations in Japan.

Japan Commercial

What A Whiz! Takeda Spins Off Discovery Op Axcelead Into New Fund

Takeda has spun off into a new joint investment fund selected drug discovery operations in Japan that had been shifted to the new Axcelead business last year, further honing its focus ahead of the Shire acquisition and in a move to foster a more effective early-stage ecosystem in the country.

Japan Research and Development Strategies

Eight Clinical Trial Read-Outs To Look Out For In Early 2018

The first three months of the year should bring late-stage clinical trial read-outs for a range of novel products including Johnson & Johnson's esketamine, Esperion's bempedoic acid, ImmuPharma's Lupuzor and VBL's gene therapy for brain cancer.

Clinical Trials Research & Development

Which Biotechs Enjoyed A 'JPM Jump' - And Which Lost Out?

As participants from this year’s J.P. Morgan Healthcare conference recover from the torrent of new information they were exposed to, Scrip explores which biotechs saw a sustainable shift in their valuations.

Commercial Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • NanoCarrier Co. Ltd.
  • Senior Management
  • Ichiro Nakatomi, PhD, Pres. & CEO
    Yasuki Kato, PhD, CSO
  • Contact Info
  • NanoCarrier Co. Ltd.
    Phone: (81) 4-7197-7621
    Chuou 144-15, 226-39 Wakashiba
    Kashiwa
    Chiba , 277-0882
    Japan
UsernamePublicRestriction

Register